Moderna Surges 13.76% as Cell Therapy Reveal and FDA Momentum Ignite MRNA.US ```json { "@context": "https://schema.org", "@type": "Article", "headline": "Moderna Surges 13.76% as Cell Therapy Reveal and FDA Momentum Ignite MRNA.US", "description": "Moderna shares rocketed $8.21 to $67.88 today, leading the broader market, after the company unveiled a new cell therapy program and built on a wave of regulatory momentum for its mRNA platform.", "image": [ "https://assets.simplefx.com/cms/f4698acb-f4af-47e2-af1b-6f9c7856194f.jpg" ], "datePublished": "2026-07-02T09:33:45.595Z", "dateModified": "2026-07-02T09:33:45.419Z", "author": { "@type": "Organization", "name": "SimpleFX", "url": "https://simplefx.com", "sameAs": [ "https://simplefx.com/social/x", "https://simplefx.com/social/linkedin", "https://github.com/SimpleFXcom/simplefx-api", "https://simplefx.com/social/facebook", "https://simplefx.com/social/youtube", "https://simplefx.com/social/telegram", "https://simplefx.com/social/tiktok", "https://www.trustpilot.com/review/simplefx.com" ] }, "publisher": { "@type": "Organization", "name": "SimpleFX", "logo": { "@type": "ImageObject", "url": "https://simplefx.com/assets/images/simplefx-logo.png", "width": 600, "height": 60 }, "url": "https://simplefx.com", "sameAs": [ "https://simplefx.com/social/x", "https://simplefx.com/social/linkedin", "https://github.com/SimpleFXcom/simplefx-api", "https://simplefx.com/social/facebook", "https://simplefx.com/social/youtube", "https://simplefx.com/social/telegram", "https://simplefx.com/social/tiktok", "https://www.trustpilot.com/review/simplefx.com" ] }, "mainEntityOfPage": { "@type": "WebPage", "@id": "https://simplefx.com/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us" }, "articleSection": "Trading Education", "keywords": "mrna.us, moderna, stocks, biotech, mrna, fda, cell-therapy, volatility", "inLanguage": "en", "isAccessibleForFree": true, "wordCount": 574, "timeRequired": "PT3M" } ``` 78% of retail investor accounts experience cash losses as a result of trading CFDs with this CFD provider. CFDs are complex instruments and carry a high risk of losing money rapidly due to leverage. 78% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. CFDs are complex instruments and carry a high risk of losing money rapidly due to leverage. 78% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. [![SimpleFX logo](./assets/images/simplefx-logo.png?v=2)](/) Offer [Promotions New Check out the latest bonus offers](/promotions "Check out the latest bonus offers") [Crypto Check out Bitcoin and altcoins on SimpleFX](/offer/crypto "Check out Bitcoin and altcoins on SimpleFX") [Forex Choose major and minor currency pairs](/offer/forex "Choose major and minor currency pairs") [Indices Engage with worldwide indexes](/offer/indices "Engage with worldwide indexes") [Commodities Choose between energy and agricultural assets](/offer/commodities "Choose between energy and agricultural assets") [Metals Dig into high in value market](/offer/metals "Dig into high in value market") [Equities Explore American, European, and Asian companies](/offer/equities "Explore American, European, and Asian companies") [Earn - Stake & Trade Make extra money from staking and trading](/earn-stake-trade "Make extra money from staking and trading") [Go to offer](/offer) Trading info [Our symbols Trade multiple financial assets](/instruments "Trade multiple financial assets") [Payment methods Multiple fiat and crypto options](/payments "Multiple fiat and crypto options") [SFX Coin Explore multiple possibilities available with our token](/sfx-simplefx-coin "Explore multiple possibilities available with our token") [Bitcoin Lightning Network Reach new heights in crypto trading](/bitcoin-lightning-network "Reach new heights in crypto trading") [Trading news Daily market analysis and news updates](/trading-news "Daily market analysis and news updates") [Zero fees Explore our free features](/zero-fees "Explore our free features") Platforms [Mobile app Trade everywhere you go](/mobile-app "Trade everywhere you go") [Desktop app Exploit the whole power of SimpleFX](/desktop-app "Exploit the whole power of SimpleFX") [Web app Utilize cutting-edge technology](/web-trader "Utilize cutting-edge technology") [Go to platforms](/platforms) [![](./assets/header/timi-logo.png) TiMi AI](/timi-ai-trade-mate) Company [About SimpleFX Check out essentials about our brand](/about "Check out essentials about our brand") [Cybersecurity awareness Find out how we protect your transactions](/cybersecurity-awareness "Find out how we protect your transactions") [Connect for business Explore tailored solutions dedicated to your business](/connect-for-business "Explore tailored solutions dedicated to your business") [Help center](/help-center) Popular search [ BRENT](/instruments/BRENT)[ BTCUSD](/instruments/BTCUSD)[ DE40](/instruments/DE40)[ ETHUSD](/instruments/ETHUSD)[ EURUSD](/instruments/EURUSD)[ INTC.US](/instruments/INTC.US)[ MSTR.US](/instruments/MSTR.US)[ MU.US](/instruments/MU.US)[ NATGAS](/instruments/NATGAS)[ NVDA.US](/instruments/NVDA.US)[ OIL](/instruments/OIL)[ SPCX.US](/instruments/SPCX.US)[ TSLA.US](/instruments/TSLA.US)[ US100](/instruments/US100)[ US500](/instruments/US500)[ USDJPY](/instruments/USDJPY)[ XAGUSD](/instruments/XAGUSD)[ XAUUSD](/instruments/XAUUSD) [Sign up](https://app.simplefx.com/signup) [Log in](https://app.simplefx.com/login) [Sign up](https://app.simplefx.com/signup) EN [EN - English](/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us) [AR - العربية](/ar/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us) [ES - Español](/es/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us) [FR - Français](/fr/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us) [HI - Hindi](/hi/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us) [ID - Bahasa Indonesia](/id/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us) [KO - Korean](/ko/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us) [MY - Malay](/my/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us) [PT-BR - Português](/pt/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us) [RU - Русский](/ru/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us) [TH - ภาษาไทย](/th/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us) [TR - Türkçe](/tr/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us) [VI - Tiếng Việt](/vi/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us) [ZH - 中文](/zh/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us) [Log in](https://app.simplefx.com/login) [Sign up now](https://app.simplefx.com/signup) Offer [Promotions New Check out the latest bonus offers](/promotions "Check out the latest bonus offers") [Crypto Check out Bitcoin and altcoins on SimpleFX](/offer/crypto "Check out Bitcoin and altcoins on SimpleFX") [Forex Choose major and minor currency pairs](/offer/forex "Choose major and minor currency pairs") [Indices Engage with worldwide indexes](/offer/indices "Engage with worldwide indexes") [Commodities Choose between energy and agricultural assets](/offer/commodities "Choose between energy and agricultural assets") [Metals Dig into high in value market](/offer/metals "Dig into high in value market") [Equities Explore American, European, and Asian companies](/offer/equities "Explore American, European, and Asian companies") [Earn - Stake & Trade Make extra money from staking and trading](/earn-stake-trade "Make extra money from staking and trading") [Go to offer](/offer) Trading info [Our symbols Trade multiple financial assets](/instruments "Trade multiple financial assets") [Payment methods Multiple fiat and crypto options](/payments "Multiple fiat and crypto options") [SFX Coin Explore multiple possibilities available with our token](/sfx-simplefx-coin "Explore multiple possibilities available with our token") [Bitcoin Lightning Network Reach new heights in crypto trading](/bitcoin-lightning-network "Reach new heights in crypto trading") [Trading news Daily market analysis and news updates](/trading-news "Daily market analysis and news updates") [Zero fees Explore our free features](/zero-fees "Explore our free features") Platforms [Mobile app Trade everywhere you go](/mobile-app "Trade everywhere you go") [Desktop app Exploit the whole power of SimpleFX](/desktop-app "Exploit the whole power of SimpleFX") [Web app Utilize cutting-edge technology](/web-trader "Utilize cutting-edge technology") [Go to platforms](/platforms) [![](./assets/header/timi-logo.png) TiMi AI](/timi-ai-trade-mate) Company [About SimpleFX Check out essentials about our brand](/about "Check out essentials about our brand") [Cybersecurity awareness Find out how we protect your transactions](/cybersecurity-awareness "Find out how we protect your transactions") [Connect for business Explore tailored solutions dedicated to your business](/connect-for-business "Explore tailored solutions dedicated to your business") [Help center](/help-center) EN - English AR - العربية ES - Español FR - Français HI - Hindi ID - Bahasa Indonesia KO - Korean MY - Malay PT-BR - Português RU - Русский TH - ภาษาไทย TR - Türkçe VI - Tiếng Việt ZH - 中文 * [](/ "Home") * [Trading news](/trading-news) * Moderna Surges 13.76% as Cell Therapy Reveal and FDA Momentum Ignite MRNA.US Moderna Surges 13.76% as Cell Therapy Reveal and FDA Momentum Ignite MRNA.US ============================================================================ Moderna shares rocketed $8.21 to $67.88 today, leading the broader market, after the company unveiled a new cell therapy program and built on a wave of regulatory momentum for its mRNA platform. Updated 16:05:11 26/06/2026 ![Moderna Surges 13.76% as Cell Therapy Reveal and FDA Momentum Ignite MRNA.US](https://assets.simplefx.com/cms/medium_f4698acb-f4af-47e2-af1b-6f9c7856194f.jpg) MRNA.US Explodes Higher, Tops the Index --------------------------------------- Moderna shares surged 13.76% on June 26, 2026, adding $8.21 to reach $67.88 — a move that placed the stock at the front of the broader equity market. The single-session gain extends an already aggressive run: over the past month, the stock has climbed 44.43%, swinging between a low of $43.86 and a high of $69.23. The six-month picture is even more striking, with a gain of 119.68% off a low of $29.02. Over the trailing twelve months, MRNA.US has advanced 151.54%, with a 52-week low of $22.24 and a 52-week high of $67.58. Cell Therapy Reveal and FDA Backing Drive the Breakout ------------------------------------------------------ Analysis suggests today's move was driven by two converging catalysts. First, Moderna unveiled a new cell therapy program at its Science Day event, with the company highlighting the expanding potential of its mRNA platform across multiple modalities. According to finance.yahoo.com, the Science Day provided a broad overview of research and early development programs, including validation of a T-cell engager modality with mRNA-2808 in multiple myeloma, supporting rapid advancement of a second T-cell engager, mRNA-2151, in ovarian cancer. The company also introduced an in vivo CAR-T modality with mRNA-6007 moving into early development for autoimmune diseases. Market drivers include the company's stated strategic direction toward becoming a diversified, multi-modality biotechnology company managing multiple commercial franchises. Second, investor confidence was reinforced by recent unanimous FDA advisory panel support for mFlusiva, Moderna's mRNA-based flu shot. Finance.yahoo.com reported that the FDA's Vaccines and Related Biological Products Advisory Committee unanimously backed mFlusiva for adults 50 and older, after phase 3 data showed it to be about 27% more effective than a standard flu vaccine. Analysis suggests this endorsement positions the mRNA platform for a potential second major commercial use beyond COVID-19. Fool.com noted the stock has already doubled this year and is still racing toward a major catalyst. Historical Highs in Sight as Momentum Builds -------------------------------------------- The one-month high of $69.23 represents the nearest overhead reference point visible in the historical data. On the downside, the one-month low of $43.86 and the six-month low of $29.02 mark the range from which the current rally has been constructed. The 151.54% gain over the trailing twelve months, off a low of $22.24, underscores the scale of the recovery. The pipeline of upcoming regulatory and clinical milestones — including the potential commercial trajectory of mFlusiva and the early-stage cell therapy programs — represents the next set of fundamental inflection points that analysis suggests the market will be watching closely. ### Risk Factors * High volatility after a 13.76% single-session move increases risk of sharp mean-reversion. * Clinical-stage programs including mRNA-2808, mRNA-2151, and mRNA-6007 carry inherent development and regulatory failure risk. * FDA advisory panel support for mFlusiva does not guarantee full regulatory approval; final agency decisions remain pending. * The stock has gained 119.68% over six months, raising the risk that near-term expectations are already priced in. * Concentration risk remains if the mRNA platform fails to achieve commercial diversification beyond COVID-19 as anticipated. * Broader market or sector-wide sentiment shifts could amplify downside given the elevated valuation implied by the 151.54% one-year gain. This article is for informational purposes only and does not constitute financial advice. Past performance is not indicative of future results. Investors should conduct their own due diligence before making any investment decisions. Price data retrieved as of 2026-06-26T16:01:05.693Z and may not reflect real-time market conditions. SimpleFX Markets Desk — real-time price movement analysis for active traders #### Ready to start investing? Sign up for SimpleFX [Sign up now](https://app.simplefx.com/signup) Or sign up with × Simple account opening. Simple way to start investing. No fees and no minimum deposits Enter your e-mail I accept the [Terms of Use](https://simplefx.com/legal-documents) & [Privacy Policy](https://simplefx.com/privacy-policy/). Open account now ![Discover SimpleFX](/assets/images/new-sfx-app-webtrader-mobile-v2@2x.png) ![SimpleFX](assets/images/simplefx-logo-white.png) Find us on [](/social/facebook)[](/social/linkedin)[](/social/youtube)[](/social/tiktok)[](/social/telegram) Join our community [](/social/x)[](/social/discord) Download SimpleFX [](https://simplefx.com/get-app/ios) Scan this QR code download app. ![](https://api.simplefx.com/mobile-store/qr/ios) [](https://simplefx.com/get-app/android) Scan this QR code download app. ![](https://api.simplefx.com/mobile-store/qr/android) [Offer](/offer) Offer [Crypto](/offer/crypto) [Forex](/offer/forex) [Indices](/offer/indices) [Commodities](/offer/commodities) [Equities](/offer/equities) [Metals](/offer/metals) [Earn - Stake & Trade](/earn-stake-trade) [Promotions](/promotions) [TiMi - AI Trade Mate](/timi-ai-trade-mate) [Go to offer](/offer) [Platforms](/platforms) Platforms [Mobile app](/mobile-app) [Desktop app](/desktop-app) [Web app](/web-trader) [Go to platforms](/platforms) Trading information [Our symbols](/instruments) [Payment methods](/payments) [SFX - SimpleFX Coin](/sfx-simplefx-coin) [Bitcoin Lightning Network](/bitcoin-lightning-network) [Zero fees](/zero-fees) [API](https://github.com/SimpleFXcom/simplefx-api) [Trading news](/trading-news) Support [Help center](/help-center) [Frequently asked questions](/faq) [Status](/status) [Currency calculator](/currency-calculator) Academy [Education](/education) [Trading glossary](/trading-glossary) Company [About us](/about) [Cybersecurity awareness](/cybersecurity-awareness) [Connect for business](/connect-for-business) [Brand assets](/brand-assets) Affiliate [Become a partner](/affiliate) [Unilink](/unilink) Privacy and Regulation [Legal documents](/legal-documents) [Rollover](/rollover) [Privacy policy](/privacy-policy) [Cookie policy](https://simplefx.com/resources/SimpleFX_CookiesPolicy.pdf) **SimpleFX Group** consists of the following entities: **8TECH LTD** authorized and supervised by the Financial Services Commission in Mauritius licence number GB23201604. Office Address: 18 Bank Street Ground Floor, Silver Bank Tower Cybercity, Ebene, Mauritius. 8TECH LTD does not provide any Fiat Exchange Services nor Cryptocurrency exchange services. 8TECH LTD does not support cryptocurrency trading accounts nor cryptocurrency deposits. **8TECH ZA (PTY) LTD** a Crypto Assets Service Provider and FSP with License No 53073 Authorized by the Financial Sector Conduct Authority (FSCA), Office address: 4 Haven Lane Malvern Queensburgh Durban Kwa-Zulu Natal 4093, South Africa. 8TECH ZA (PTY) LTD offers cryptocurrency deposits and supports cryptocurrency trading accounts based on the FSCA license No 53073 with crypto assets subcategory. **8TECH PA LLC** licensed by the Kuna de Wargandí International Services Authority (KUNAISA) under FOREX Licence No. FX0032026 and VASP Licence No. V0042026, with company number 0004-IBC-2026 and its registered address at Central Street, Kunaisa Bldg., Nurrá-Wala-Mortí, Kuna de Wargandí Territory, Republic of Panama. 8TECH PA LLC is the owner of the website SimpleFX: Free trading & investing platform. **SimpleFX Group** is not authorized by any EU authority, EEA National Competent Authority or the United Kingdom. SimpleFX services are outside the EU and the UK regulatory framework. You will not be covered by the Investor Compensation Fund. The information on this website does not constitute, nor should it be construed or understood as an inducement or solicitation to engage in any investment or trading activity and is not intended as a marketing or promotion of the SimpleFX services to citizens of the EU, the EEA or the UK. **SimpleFX Group** does not provide services to citizens and residents of the United States or any country where such distribution or use would be contrary to local law or regulation. **RISK WARNING** Margin trading in foreign currency, virtual assets or other off-exchange products on margin carries a high level of risk and may not be suitable for everyone. We advise you to carefully consider whether trading is appropriate for you in light of your personal circumstances. CFDs are complex instruments and carry a high risk of losing money rapidly due to leverage. 78% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Tax may be payable on any profits and you should seek independent advice on your taxation position. 2026 SimpleFX. All rights reserved. [ Write to us. We respond 24/5. ](https://app.simplefx.com/login?action=open-livechat)